RESEARCHERS believe four cancer-fighting drugs may also work in treating rheumatoid arthritis.
In an exciting discovery, a team of international scientists has uncovered new regions of DNA involved in rheumatoid arthritis, identifying genes which are known to be the targets of already approved chemotherapy drugs.
University of Queensland Diamantina Institute director Matthew Brown, who was involved in the research, said it paved the way for human trials of new treatments for rheumatoid arthritis, a painful, debilitating condition caused by immune system dysfunction.
Professor Brown said the study, to be published in the prestigious journal Nature , showed how genetic research could be used to find potential new treatments for diseases among existing drugs, getting medications to patients earlier.
“It short-cuts by many years the time taken between the genetic research and clinical trials,” he said. “For existing drugs, there’s no toxicology testing required, no extra studies needed to look at safety before you can think about doing trials in humans because they’ve already been done.
“It takes 10 years off the process of developing drugs and greatly reduces the cost.”
Professor Brown said genetics had made huge inroads into finding the causes of common diseases in the past decade.
“This study shows one way forward that will turn those discoveries much more rapidly into treatments, which is what we all strive for in research,” he said.
The researchers identified 48 new genes as the most likely culprits in the development of rheumatoid arthritis, nearly doubling the number known to be involved.
About 65 per cent of a person’s risk for the disease is believed to be genetic, with environmental factors also implicated. For example, smoking is a known trigger in genetically susceptible people.
It affects about one in 100 people and is more common in women, than men.
The Latest on: Rheumatoid arthritis
[google_news title=”” keyword=”Rheumatoid arthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Rheumatoid arthritis
- Treat-to-Target Strategy Results in Long-Term Remission in Rheumatoid Arthritison May 7, 2024 at 6:45 am
Researchers assessed whether the positive results of a treat-to-target approach for rheumatoid and undifferentiated arthritis persisted long-term.
- Celltrion's Remsima SC grabs 40% market share in Germanyon May 7, 2024 at 1:06 am
Celltrion is quickly expanding its presence in Germany, with its rheumatoid arthritis copycat drug Remsima SC grabbing nearly 40 percent of the local market, more than a 10-fold surge in just four ...
- Jolt Health To Acquire HCQ Transdermal Patch Technologyon May 6, 2024 at 1:26 pm
FDA Approved and Viability to Address Underserved Lupus, Rheumatoid Arthritis and Malaria market, forecast to be worth $6 Billion USD by 2027* ...
- Lupin rolls out Rymti biosimilar Etanercept in Canadaon May 6, 2024 at 6:21 am
Lupin’s Etanercept was first approved for the treatment of rheumatoid arthritis by PMDA in 2019, EMA in 2020, Health Canada in 2022, and since then has offered an effective treatment option for ...
- Researchers unveil unique autoantibody profiles in rheumatoid arthritis patientson May 2, 2024 at 6:42 am
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease.
- What Is Psoriatic Arthritis? 3 MDs Weigh Inon May 1, 2024 at 12:15 pm
About 30 percent of people with psoriasis will develop psoriatic arthritis. Here's what to know about symptoms and treatment.
- Patients with rheumatoid arthritis have unique and complex autoantibody patterns, study revealson April 30, 2024 at 9:00 pm
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity ...
- Patients with rheumatoid arthritis have unique and complex autoantibody patternson April 30, 2024 at 5:00 pm
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity ...
- Rheumatoid Arthritis Patients Have Unique Autoantibody Patternson April 30, 2024 at 5:00 pm
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity ...
- Which Vitamins Are Good For Arthritis?on April 29, 2024 at 2:18 pm
Maintaining adequate vitamin D levels is critical for bone health, as it helps bones absorb calcium. The vitamin also regulates the immune system and may help reduce inflammation in the joints. In ...
via Bing News
